The use of HSP90 inhibitor AUY922 with platin-based radiation has shown efficacy in synergistic killing of mutant head and neck squamous cell carcinoma (HNSCC) cells through chromosomal fragmentation [119]. This evidence concerns the gene HSP90AA1 and head and neck squamous cell carcinoma.